Table 1.
Genomic Variation | Variant Type | Protein Effect | Sex | Platelet Expression | Age at Diagnosis | Age at Presentation | Bleeding Symptoms | Ref | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E | SC | M | DE | S | GI | ||||||||
c.742G>T | Missense | p.Gly248Trp | F | Yes | 55 | 1 year | [58] | ||||||
H | Yes | 53 | 1 year | ||||||||||
H | Yes | 49 | 1 year | ||||||||||
c.337C>T | Stop codon | p.Arg113* | F | No | 55 | Lifelong | [59] | ||||||
M | No | 46 | Childhood | ||||||||||
c.1142C>T | Missense | p.Ser381Phe | M | No | 9 | lifelong | [59] | ||||||
c.1142C>T c.659G>A |
Missense Missense |
p.Ser381Phe p.Arg220Glu |
F | N/D | 41 | Early childhood | [90] | ||||||
c.925A>T c.1081_1083delCTG |
Stop codon Deletion |
p.Lys309* p.Leu360del |
F | No | 16 | Before 3 years | [89] | ||||||
c.706C>T | Stop codon | p.Gln236* | M | No | 8 | 1 year | [60] | ||||||
c.887G>A | Missense | p.Cys296Tyr | F | No | 4 | First year | [60] | ||||||
c.914G>A | Missense | p.Gly305Asp | M | No | 9 | Early childhood | [89,91] | ||||||
M | Yes (Residual) | 24 | 2 years | ||||||||||
c.199delAA | Frameshift | p.Asn67Leufs*24 | F | No | 23 | 1 year | [91] | ||||||
c.372-3C>G | Splice variant | p.(Pro125*) | F | N/D | 24 | 2 years | [91] | ||||||
c.990C>G | Missense | p.Asn330Lys | F | N/D | 21 | 5 years | [91] | ||||||
c.778G>T c.886T>C |
Stop codon Missense |
p.Glu260* p.Cys296Arg |
F | No | 20 | 1 year | [91] | ||||||
c.1482InsG | Frameshift | p.Arg494Alafs*54 | M | N/D | 60 | 5 years | [91] | ||||||
c.1482InsG c. 542T>C |
Frameshift Missense |
p.Arg494Alafs*54 p.Phe181Ser |
M | N/D | 13 | 1 year | [91] | ||||||
c.1490delT | Frameshift | p.Phe497Serfs*22 | M | Yes (Lower MW) | 45 | 5 years | [84,91] | ||||||
F | Yes (Lower MW) | 55 | During the first year | ||||||||||
c.1490delT c.1033G>C |
Frameshift Missense |
p.Phe497Serfs*22 p.Ala345Pro |
M | N/D | 57 | 5 years | [91] | ||||||
c.1490delT c.866A>G |
Frameshift Missense |
p.Phe497Serfs*22 p.Tyr289Cys |
M | N/D | 61 | 4 years | [91] | ||||||
c.74-1G>C | Splice variant | p.(Asp25Ala*15) | M | N/D | 9 | 3 years | [92] | ||||||
c.337delC | Deletion | p.Arg113Aspfs*6 | M | N/D | 9 | During the first year | [93] | ||||||
c.742G>C | Missense | p.Gly248Arg | F | N/D | 15 | Early childhood | [94] | ||||||
Newly identified variant | |||||||||||||
c.1507G>T | Stop codon | p.Glu503* | M | N/D | 14 | Early childhood | |||||||
% of patients | 96 | 84 | 73 | 40 | 40 | 16 |
Blue background corresponds to RASGRP2 composite heterozygous variants; pink background corresponds to a RASGRP2 variant associated to a P2RY12 heterozygous variant; yellow background corresponds to a RASGRP2 variant associated to a FERMT3 homozygous variant. E = Epistaxis, SC = Subcutaneous hemorrhage, M = Menorrhagia, DE = Prolonged bleeding after dental extraction, S = Prolonged bleeding after surgery and GI = Gastrointestinal hemorrhage.